Eloxx Pharmaceuticals Inc expected to post a loss of $2.55 a share - Earnings Preview

Eloxx Pharmaceuticals

02/05/2023 19:33

* Eloxx Pharmaceuticals Inc  ELOX.OQ   ELOX.O  is expected
to show
a rise in quarterly revenue when it reports  results on May 4
(estimated). 
    * The Watertown Massachusetts-based  company is expected to
report
revenue of $700 thousand, according to the estimate from one
analyst, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Eloxx
Pharmaceuticals Inc
is for a loss of $2.55 per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts had risen by
about 32.5%
in the last three months. ​
    * Wall Street's median 12-month price target for Eloxx
Pharmaceuticals Inc is $50​, above​ its last closing price
of $6.96. ​​​

This summary was machine generated May 2 at 18:33 GMT.  All
figures in US dollars  unless otherwise stated